Loading clinical trials...
Loading clinical trials...
A Multi-centre, Randomised, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
Conditions
Interventions
BCG-10 vaccine
0.9% saline
Locations
6
Poland
Department of Anesthesiology and Intensive Care, University Clinical Center, School of Medicine in Katowice, Medical University of Silesia
Katowice, Poland
Stefan Żeromski Specialist Hospital
Krakow, Poland
Voivodeship Hospital nr 2 in the Name of The Saint Queen Jadwiga, University of Rzeszów, Poland
Rzeszów, Poland
Saint Jadwiga Śląska Hospital
Trzebnica, Poland
Department of Pediatrics, Bielanski Hospital,
Warsaw, Poland
Praski Hospital
Warsaw, Poland
Start Date
July 7, 2020
Primary Completion Date
December 1, 2020
Completion Date
April 1, 2021
Last Updated
December 2, 2020
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Hanna Czajka
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions